Mission Dissolvable: Oral Thin Film Technology
Learn about the benefits of ARx Thin Films and Transdermal Patches at Drug Delivery Partnerships 2017
February 3, 2017
The Criticality of Adhesive Selection
February 13, 2017

Mission Dissolvable: Oral Thin Film Technology

Originally published in 2012 by ARx Technical Director, Scott Barnhart, this article speaks to relevant challenges and benefits seen in the drug market today, specifically, the possibilities and benefits of mucosal thin film delivery. Learn how mucosal delivery has evolved over the past few years in promising clinical trials and emerging opportunities for further therapeutic benefits of new and existing drug products: Mission Dissolvable.